EndoCure News
6 articles
growth-positive
Endometriosis: Better diagnostic tool under development - ISRAEL21c
EndoCure, a startup based in Haifa, Israel, is developing a diagnostic tool for endometriosis, a disease that affects an estimated 200 million women worldwide. The tool uses an enhanced form of ultrasound combined with artificial intelligence to identify and map tiny lesions in the pelvic cavity, which are often invisible to standard imaging systems. The company, which was officially launched in November 2023, has received a small investment from Technion Prof. Moshe Shoham and a grant from the Israel Innovation Authority. EndoCures CEO, Hadas Ziso, hopes to market the product within two or three years.
InvestmentExpand
growth-positive
Seven start-ups to go head-to-head at Femtech World Awards
Cross-Border Impact Ventures has shortlisted seven femtech start-ups for the OB/GYN Innovation award. The company is dedicated to investing in early-growth stage health technology companies that are commercialising medical devices, diagnostics, therapeutics and digital health innovations. All financed innovations are relevant to women, children and adolescent health and are located in North America, Europe and Israel. The shortlisted companies include Nesa Medtech, EndoCure, Hale, Lasa Health, Sonio, Aspivix, and Yeda. The winner will be announced at a virtual event on May 2.
Investment
growth-positive
New solutions for diagnosing endometriosis
Femtech companies are developing new ways to diagnose and treat endometriosis, a condition that affects an estimated 1 in 10 women. Companies such as Ziwig, Hera Biotech, Endodiag, and Dotlab are researching less invasive diagnostic methods, including saliva tests, blood tests, and period blood tests. Other companies, such as IMAGENDO and Endocure, are using artificial intelligence and machine learning to improve the accuracy of ultrasound and MRI scans. Treatment options are also being explored, with companies like Myoovi and Menstruflow developing devices to manage pain, and FimmCyte working on a non-hormonal drug to reduce inflammation and pain.
CustomersPartnersInvestmentAcquisitionExpand
growth-positive
The audacious Israeli entrepreneurs founding startups during the war | CTech
Despite the war and its impacts, Israeli entrepreneurs continue to establish new ventures. Gal Admati, who was displaced from his home, founded a food tech company called Qortein and an AgriTech startup called HarvestR from his hotel room. Despite concerns about funding cuts due to the war, the Innovation Authority and the InNegev tech incubator provided funding for the startups. Another startup, EndoCure, which has developed an AI-based robotic ultrasound system, was founded by Dr. Hadas Ziso and Prof. Moshe Shoham amidst the war. The company received a grant from the Innovation Authoritys startup fund. Despite the challenging circumstances, these entrepreneurs are optimistic about their ventures.
InvestmentExpand
growth-positive
דווקא עכשיו: היזמים שהקימו סטארט-אפ בזמן המלחמה | כלכליסט
The article discusses the establishment of startups during wartime, focusing on the story of Curtain, a foodtech company founded in October 2021 during a war. The company was founded by Gal Admati from a hotel room after he was displaced due to the war. Despite the challenging circumstances, Admati was determined to continue with his venture, working with the Innovation Authority to secure funding. The article also mentions other entrepreneurs who started their companies during the war, highlighting their resilience and determination.
Investment
growth-positive
EndoCure was selected as TOP12 at MEDICA STARTUP COMPETITION out of 280 submissions!
Navispace has announced the winners of the 12th MEDICA Startup Competition at the MEDICA CONNECTED HEALTHCARE FORUM. The competition was judged based on innovation, technological viability, market approach, commercial potential, and sustainability. The winner of the competition was MeMed, with Sidekick Health Germany and ROPCA taking second and third place respectively. The competition was judged by a panel from HTGF | High-Tech Gründerfonds, Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI), GE HealthCare, ETH Zürich, and KUKA.
Partners
